Case report shows effective management of dyslipidaemia and reduced lipase levels in acute pancreatitis.
Dyslipidaemia can be a cause of acute pancreatitis, but the improper management may lead to mortality. The present case report was presenting dyslipidaemia associated acute pancreatitis, which was diagnosed and treated accordingly in the eastern part of India. A 27-year-old nonhypertensive newly diagnosed male presented with acute onset of severe abdominal pain (epigastric pain) radiating towards back and history of occasional alcohol intake and smoking. He had a sign of tender abdomen. He found with increased level of serum amylase (950 U/L) and lipase (420 U/L) and CECP whole abdomen showed the presence of acute pancreatitis. The blood investigations confirmed dyslipidaemia (TG = 2120 and TC = 710 mg/dl) and Saroglitazar 4 mg and Iv insulin was given. After treatment, the patient observed decreasing level of serum amylase (743 U/L) and lipase (247 U/L). Finally, TC and TG values were decreased of about 210 and 201 mg/dl, respectively. The patient was discharged from the hospital. The present case indicated the dyslipidaemia-associated pancreatitis as per blood parameters and CT scan, but the management was beneficial to treat this disorder in this case.
No takes yet. Share an insight, caveat, or question.
Pradipta Bhattacharjee (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: